EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessment of TNF-α, IL-12/23, and IL-17 in Psoriasis: Only TNF-α Reflects Clinical Response After 12 Weeks of Biologic Treatment

Alessandra-Mădălina Matei-Man iD, Ștefan Cristian Vesa iD, Alexandra Dana Pușcaș iD, Meda Sandra Orăsan, Bianca Homorozeanu, Elisabeta Candrea, Teodora Mocan

Current Issues in Molecular Biology · 16.05.2025 · 47 (5) · 368

DOI: 10.3390/cimb47050368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 16.05.2025. Verfasst von Alessandra-Mădălina Matei-Man und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Faculty of Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400126 Cluj-Napoca, Romania. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tumor necrosis factor-alpha (TNF-α), IL-12/23, IL-17A, and IL-17F are key proinflammatory cytokines involved in the pathogenesis of psoriasis. Biologic therapies targeting these interleukins have demonstrated clinical efficacy. However, the exact relationship between their serum levels and clinical response remains unclear. The aims of this study are to assess changes in cytokine levels (TNF-α, IL-12/23, IL-17A, IL-17F) after 12 weeks of biologic treatment in psoriasis to test if there is any correlation between their serum level and PASI (Psoriasis Area Severity Index) and DLQI (Dermatology Life Quality Index) scores before or after treatment and to check the influence of clinical and lifestyle factors on these levels.

Methods

In this prospective study, 36 patients with moderate-to-severe plaque psoriasis receiving anti-TNF-α, anti-IL-17, or anti-IL-23 therapy were assessed at baseline and after 12 weeks. The serum levels of these cytokines were measured using the ELISA technique. Clinical response was evaluated using PASI and DLQI scores. Spearman correlation analysis was used to assess the relationship between interleukins’ serum levels and these scores.

Results

A significant decrease in TNF-α levels and DLQI and PASI scores was observed after 12 weeks across all treatments. A moderate positive correlation (r = 0.391, p = 0.018) was found between serum TNF-α levels and PASI scores at week 12.

Conclusions

The serum levels of TNF-α are significantly correlated with PASI scores following 12 weeks of biologic therapy, supporting their potential role as a biomarker for monitoring treatment efficacy in psoriasis.

Schlagwörter

Stichwörter der Autor:innen

TNF-αbiologic therapybiomarkerspsoriasis

Autor:innen und Institutionen

  • Dermatology Department, Faculty of Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400126 Cluj-Napoca, Romania.
  • Department of Pharmacology, Toxicology and Clinical Pharmacology, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania.
  • Independent Researcher, 1021 Budapest, Hungary.
  • Physiopathology Department, Faculty of Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400126 Cluj-Napoca, Romania.
  • Department of Radiation Oncology, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
  • Physiology Department, Faculty of Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400126 Cluj-Napoca, Romania.

ORCID-Profile: Alessandra-Mădălina Matei-Man, Ștefan Cristian Vesa, Alexandra Dana Pușcaș

Zitieren

APA

Matei-Man, A. M., Vesa, Ș. C., Pușcaș, A. D., Orăsan, M. S., Homorozeanu, B., Candrea, E., & Mocan, T. (2025). Assessment of TNF-α, IL-12/23, and IL-17 in Psoriasis: Only TNF-α Reflects Clinical Response After 12 Weeks of Biologic Treatment. Current Issues in Molecular Biology, 47(5), 368. https://doi.org/10.3390/cimb47050368

Vancouver

Matei-Man AM, Vesa ȘC, Pușcaș AD, Orăsan MS, Homorozeanu B, Candrea E, et al. Assessment of TNF-α, IL-12/23, and IL-17 in Psoriasis: Only TNF-α Reflects Clinical Response After 12 Weeks of Biologic Treatment. Current Issues in Molecular Biology. 2025;47(5):368. doi:10.3390/cimb47050368

BibTeX
@article{MateiMan2025,
  author = {Matei-Man, Alessandra-Mădălina and Vesa, Ștefan Cristian and Pușcaș, Alexandra Dana and Orăsan, Meda Sandra and Homorozeanu, Bianca and Candrea, Elisabeta and Mocan, Teodora},
  title = {Assessment of TNF-α, IL-12/23, and IL-17 in Psoriasis: Only TNF-α Reflects Clinical Response After 12 Weeks of Biologic Treatment},
  journal = {Current Issues in Molecular Biology},
  year = {2025},
  volume = {47},
  number = {5},
  pages = {368},
  doi = {10.3390/cimb47050368}
}
Kostenlos starten →